Found 36 matching trials
Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy PHASE1 RATIONALE: Vaccines made from a person's peripheral stem cells may make the...
Show More Location
Jonsson Comprehensive Cancer Center, UCLA
Learn More & Join Trial
Provenge® (Sipuleucel-T) Active Cellular Immunotherapy Treatment of Metastatic Prostate Cancer After Failing Hormone Therapy PHASE3 Provenge is an investigational product designed to activate a man's own ant...
Show More Location
South Orange County Urological
Learn More & Join Trial
PEP-DC and OC-DC Vaccine in High Grade Serous Ovarian Carcinoma PHASE1 Single center, phase I/II randomized 2-arm study, evaluating two different ...
Show More Location
Multiple Locations
Learn More & Join Trial
Autologous Dendritic Cells Loaded With Autologous Tumor Associated Antigens for Treatment of Advanced Epithelial Ovarian Carcinomas PHASE2 This is a double-blind study in which approximately 99 study patients will ...
Show More Location
Disney Family Cancer Center
Learn More & Join Trial
Dendritic Cell Based Therapy of Malignant Melanoma PHASE1 The aim of the study is to show if vaccination with autologous dendritic ce...
Show More Location
Department of Oncology, Copenhagen University Hospital, Herlev
Learn More & Join Trial
Specialized Immune Cells (nCTLs) and a Vaccine (Alpha-type-1 Polarized Dendritic Cells) in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer PHASE1 This phase I/IIa trial studies the side effects and best dose of a type of ...
Show More Location
Roswell Park Cancer Institute
Learn More & Join Trial
IKKb-matured, RNA-loaded Dendritic Cells for Metastasised Uveal Melanoma PHASE1 A Phase I vaccination trial in patients suffering from recently diagnosed m...
Show More Location
University Hospital Erlangen Dept. of Dermatology
Learn More & Join Trial
Randomized Trial With Dendritic Cells in Patients With Metastatic Colorectal Cancer PHASE2 The different alternatives used since 1996 to treat metastatic colorectal c...
Show More Location
Hospital Clínic Barcelona
Learn More & Join Trial
Safety of AV-MEL-1 With Anti-PD-1 Therapy in Metastatic Melanoma PHASE1 This is an open label, single-arm, phase IB treatment study to determine th...
Show More Learn More & Join Trial
Phase I/II Study of Vaccination With Antigen Loaded Dendritic Cells (DCs) in Hormone-Refractory Prostate Cancer PHASE1 The main aim of this trial is to assess the response rate, the feasibility ...
Show More Location
Multiple Locations
Learn More & Join Trial